GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Concord Biotech Ltd

Concord Biotech Ltd Board Meeting to Discuss Q2 FY27 Results

BOARD ◆ Monitor Closely LOW RISK
📅 Filed on BSE: 22 Oct 2026, 09:43 AM IST  ·  BSE ID: 5e8ab3d3-303e-4c7f-badd-252b784c4673
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's directors will meet to review and approve the latest financial results, which cover the period up to September 2026.
🤖 AI Summary
  • Concord Biotech board meeting scheduled for October 27, 2026.
  • Agenda includes approval of unaudited Q2 and H1 FY27 financial results.
  • Statutory auditors' limited review report to be presented.
  • Trading window closure extended by 48 hours post-results announcement.
🏢 How This Affects the Company
📈
Business Impact
The announcement prepares stakeholders for the release of financial performance data, informing future business outlook assessments.
💰
Financial Impact
The upcoming results will provide clarity on the company's financial health and profitability for the specified periods.
⚙️
Operational Impact
None directly stated in this filing regarding operational changes.
⚠️
Risk Impact
Disclosure of financial results is standard practice and does not introduce new risks beyond market interpretation.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders. Shareholders should await the release of the financial results.
👤
Who Is Affected
All shareholders are affected as the upcoming results will provide information on the company's financial performance.
🔍
Management Signal
The timely scheduling of the board meeting signals management's adherence to regulatory disclosure timelines for financial reporting.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Board meeting on October 27, 2026.
Release of unaudited Q2 FY27 financial results.
Review of auditor's limited review report.
LOW RISK This is a routine procedural disclosure for financial results, carrying no inherent new risks.
💡 Investor Takeaway
Concord Biotech Ltd will announce its unaudited standalone and consolidated financial results for Q2 and H1 FY27 on October 27, 2026, subject to board approval and auditor review.
❓ Frequently Asked Questions
When will Concord Biotech Ltd's board meeting be held?
The board meeting of Concord Biotech Ltd is scheduled to be held on Tuesday, October 27, 2026.
What is the purpose of Concord Biotech Ltd's board meeting on October 27, 2026?
The meeting is to consider and approve the unaudited Standalone and Consolidated Financial Results for the second quarter and half year ended September 30, 2026.
Will Concord Biotech Ltd also consider the auditor's report?
Yes, the board meeting will also consider the Limited Review Report on the unaudited Standalone and Consolidated Financial Results, to be issued by the Statutory Auditors.
When will the trading window reopen for Concord Biotech Ltd?
The trading window for Concord Biotech Ltd will remain closed up to 48 hours after the declaration of the financial results for the second quarter and half year ended on September 30, 2026.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.